Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Insights - The company reported a revenue of 14.26 billion yuan for 2025, representing a year-on-year growth of 20.83%. The net profit was 1.06 billion yuan, down 18.37% year-on-year, but the adjusted net profit was 1.53 billion yuan, up 1.3% year-on-year [7] - The HNB (Heat Not Burn) business is expected to ramp up, with significant growth in the electronic atomization segment. The company is also expanding into new business areas such as medical and beauty atomization, which are anticipated to provide long-term growth opportunities [7] - The company is positioned as a global leader in atomization technology, with a multi-business matrix that is steadily advancing despite tightening regulatory policies [7] Financial Summary - Total revenue projections for the company are as follows: - 2024: 11.80 billion yuan - 2025: 14.26 billion yuan - 2026: 16.62 billion yuan - 2027: 19.77 billion yuan - 2028: 23.34 billion yuan - The projected net profit for the years 2026 to 2028 is as follows: - 2026: 1.26 billion yuan - 2027: 1.88 billion yuan - 2028: 2.79 billion yuan - The earnings per share (EPS) is projected to be: - 2024: 0.21 yuan - 2025: 0.17 yuan - 2026: 0.20 yuan - 2027: 0.30 yuan - 2028: 0.45 yuan [1][8]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Insights - The company reported a revenue of 14.26 billion yuan for 2025, representing a year-on-year growth of 20.83%. However, the net profit was 1.06 billion yuan, down 18.37% year-on-year. Adjusted net profit was 1.53 billion yuan, showing a slight increase of 1.3% [7] - The HNB (Heat Not Burn) business is expected to ramp up, while the electronic atomization segment is recovering steadily. The company is expanding its product matrix and has launched HNB products in various international markets, aiming for increased market share [7] - The company is positioned as a global leader in atomization technology, with ongoing growth opportunities in electronic atomization and new business ventures in medical and beauty atomization [7] Financial Projections - Total revenue projections for the company are as follows: 2024A: 11.8 billion yuan, 2025A: 14.26 billion yuan, 2026E: 16.62 billion yuan, 2027E: 19.77 billion yuan, and 2028E: 23.34 billion yuan [1] - The projected net profit for 2026 is 1.26 billion yuan, with further increases expected in subsequent years, reaching 2.78 billion yuan by 2028 [1] - The earnings per share (EPS) is forecasted to be 0.21 yuan for 2024, decreasing to 0.17 yuan for 2025, and then gradually increasing to 0.45 yuan by 2028 [1] Business Performance - The company’s self-owned brand and B2B business segments reported revenues of 29.12 billion yuan and 113.44 billion yuan respectively, with year-on-year growth rates of 17.6% and 21.7% [7] - The HNB revenue reached 12.87 billion yuan, showing a significant year-on-year increase of 475.4%, while European and American atomization revenues grew by 18.5% and 2.1% respectively [7] - The adjusted net profit margin for the second half of 2025 was 9.6%, with a year-on-year decrease of 1.6 percentage points, indicating a narrowing decline compared to the first half [7]

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Views - The company is expected to see a long-term growth trajectory despite short-term fluctuations, with a focus on the recovery of its vaping business [1] - The company has demonstrated strong performance in its mature vaping business, with a notable recovery in overall performance [2] - The HNB (Heat-not-Burn) segment is experiencing significant growth, with a projected revenue increase of 476% year-on-year [3] - The emerging medical and beauty vaping business is in the exploratory phase, with high R&D investments impacting short-term performance but offering substantial long-term profit potential [3] - The company is expected to maintain a high dividend yield, reflecting confidence in future growth [4] Summary by Sections Financial Performance - In 2025, the company achieved a revenue of 14.3 billion HKD, a year-on-year increase of 21%, while the net profit attributable to shareholders was 1.06 billion HKD, a decrease of 19% [1] - The adjusted net profit for 2025 was 1.53 billion HKD, reflecting a year-on-year increase of 1.3% [1] - The company plans to distribute a dividend of 0.2 HKD per share for 2025 [1] Business Segments - The vaping business in the US and Europe showed revenue growth of 19% and 2% respectively, while the Chinese market saw a decline of 11% [2] - The company's own brand generated revenue of 2.9 billion HKD, with significant growth in the US and European markets [2] - The HNB segment generated 1.3 billion HKD in revenue, with plans for expansion into key markets like Japan and Poland [3] - The medical and beauty vaping segment is preparing for FDA approval and aims to build small-scale production capabilities [3] Future Projections - Revenue projections for 2026-2028 are 16.91 billion HKD, 19.98 billion HKD, and 23.66 billion HKD, with year-on-year growth rates of 18.64%, 18.13%, and 18.42% respectively [4] - Net profit projections for the same period are 1.65 billion HKD, 2.57 billion HKD, and 3.49 billion HKD, with growth rates of 55.20%, 55.58%, and 35.69% respectively [4] - The expected EPS for 2025-2027 is 0.27 HKD, 0.41 HKD, and 0.56 HKD, with corresponding P/E ratios of 42, 27, and 20 times [4]

Group 1 - The core viewpoint of the news highlights the significant rebound of Smoore International's stock price, which surged by 8.99% to HKD 12 per share, with a market capitalization of approximately HKD 74.33 billion. However, the stock has experienced a cumulative decline of over 50% since late August 2025, and over 80% from its peak in 2021, reflecting market concerns about regulatory pressures, intensified competition, and profit pressures in the e-cigarette industry [2] - Analysts suggest that the substantial price drop has released pessimistic expectations, indicating that any marginal improvement in fundamentals or signals of industry optimization could act as catalysts for stock price recovery [2] - Institutions believe that the rectification of illegal practices in domestic e-cigarette production, sales, and exports, along with overseas policies promoting the exit of illegal products, will optimize the supply-side landscape of the e-cigarette industry. Smoore International, as a compliant listed leader, is expected to benefit directly from this trend [2] Group 2 - The Ministry of Finance and the State Administration of Taxation announced that from April 1, 2026, the export tax rebate for e-cigarettes and other products will be canceled. This policy adjustment is viewed as accelerating industry consolidation, which will benefit leading compliant enterprises with scale and technological advantages in the long term [3] - The adjustment is expected to significantly impact the e-cigarette manufacturing industry, leading to a new round of reshuffling. Although Smoore's short-term performance may be affected by the tax rebate policy, its long-term position is expected to be further solidified [3] - In response to the sluggish stock price, the company's management has demonstrated confidence through actions such as two share buybacks in mid-December, costing nearly HKD 200 million, which is seen as a move to build a price floor [3] Group 3 - Looking ahead, institutional sentiment has turned optimistic. Analysts from Guotai Junan Securities state that Smoore International, as a global leader in electronic vaporization, is committed to increasing R&D and technological leadership. With the strengthening of global regulatory measures and continuous expansion of new businesses, coupled with recent large-scale buybacks reflecting long-term confidence, the company's future development potential is clear [3] - Guangfa Securities recently noted that Smoore's existing business is showing signs of recovery, and there is significant growth potential in the HNB (Heat-Not-Burn) segment. The company's HNB products are being rapidly rolled out in Japan and Europe, leading to stronger performance certainty [3]

Investment Ratings - The report provides a positive outlook on the new tobacco industry, indicating a steady upward trend, while the home furnishing and packaging sectors are stabilizing at the bottom [6][11][15]. Core Insights - The report highlights the marketing strategies around the Spring Festival and Valentine's Day for trendy toys, with companies like Pop Mart and Blok launching limited series to enhance IP value and collectability [7][8]. - In the new tobacco sector, the necessity for domestic development is emphasized, with major players increasing investments in heated tobacco products (HNB) and innovative marketing strategies [11][12]. - The home furnishing market is experiencing a contraction in sales, with significant declines in both new and second-hand property transactions, but there are signs of potential recovery driven by policy support [13][14]. - The packaging industry is expected to benefit from a steady recovery in downstream demand, supported by growth in consumer goods sectors [15][16]. - The pet food industry is facing increased competition, leading to higher sales expense ratios, but listed companies are leveraging their financial advantages for mergers and acquisitions [21]. Summary by Sections Trendy Toys - Focus on marketing strategies for key holidays, with companies like Pop Mart and Blok launching special editions to enhance brand value [7]. - The integration of AI in toys is gaining traction, with companies like Kid King and JD.com developing AI products to meet family needs [8][9]. New Tobacco - The report notes a projected decline in electronic cigarette exports, with a focus on the need for innovation in the domestic market [11]. - Major tobacco companies are increasing their investments in HNB products, indicating a significant growth potential in this segment [12]. Home Furnishing - The report indicates a significant drop in property transactions, with new home sales down 29.23% year-on-year and second-hand home sales down 8.94% [13]. - Despite current challenges, there is optimism for recovery in the home furnishing sector due to supportive policies [14]. Packaging - The packaging sector is expected to see a recovery in demand, with growth in consumer goods contributing positively to the industry [15][16]. - The report highlights price fluctuations in raw materials, particularly in the paper and aluminum sectors, which could impact packaging costs [15]. Pet Food - Increased competition in the pet food industry is leading to higher sales expenses, but established companies are positioned to benefit from consolidation opportunities [21]. - The report suggests focusing on companies with strong brand recognition and those actively pursuing mergers and acquisitions [21].

Core Viewpoint - The company demonstrates strong confidence in its future development by repurchasing 8.14 million shares at an average price of 12.26 HKD per share, totaling 99.77 million HKD [1] Business Analysis - The Hilo product's capabilities are being validated, with British American Tobacco (BAT) increasing promotional efforts. In the Japanese market, BAT is actively promoting online and offline marketing activities, achieving a retention rate of approximately 50% among traditional cigarette and heated tobacco consumers, which supports the strong product performance of Hilo [1] - Hilo has significantly increased promotional offers in the Polish market, with Hilo devices bundled with two packs of cartridges priced at only 1 Zloty, and Hilo Plus devices with two packs at 79 Zloty. This strategy, supported by BAT's extensive sales network and marketing resources, is expected to drive continued sales growth of Hilo cartridges, contributing to core profit increments for the company [1] - The core vaping business is recovering and is expected to benefit from the expansion of the European and American markets. In 2024, U.S. regulatory authorities are intensifying efforts against illegal e-cigarettes, which is severely squeezing the market for illegal products. The FDA has cautiously supported the expansion of flavored tobacco, indicating a potential for continued market growth [2] - The European market is transitioning from disposable to refillable and open-system products, with BAT's U.S. market revenue expected to rebound in the second half of 2025. The global core market share is projected to increase by 0.1 percentage points by the end of 2024, with the U.S. market alone expected to grow by 0.7 percentage points [2] - BAT plans to accelerate the global promotion of Hilo by 2026 to capture market share across various segments of heated tobacco, amidst increasing competition from products like IQOS and heated tobacco from Japan. The long-term trend of increasing penetration of new tobacco products overseas is confirmed, with the company leveraging its technological strength and production capacity to maintain a prominent position in the industry [2] - The upward trend in the company's vaping and heated non-burn (HNB) businesses remains unchanged, with positive signals emerging across various operations, suggesting a need for active attention [2] Profit Forecast, Valuation, and Rating - The company forecasts EPS for 2025, 2026, and 2027 to be 0.22, 0.37, and 0.59 CNY respectively, with current stock prices corresponding to PE ratios of 53, 31, and 20 times, maintaining a "buy" rating [3]

Group 1 - The core viewpoint of the report is that Smoore International (06969) is positioned to benefit from the expansion of the compliant vaping market in Europe and the US, supported by its strong technological capabilities and production capacity [1] - The company has announced a share buyback of 8.14 million shares at an average price of HKD 12.26, totaling HKD 99.77 million, reflecting confidence in its future development [1] Group 2 - Hilo's product strength is being validated, with British American Tobacco (BAT) increasing promotional efforts, leading to a retention rate of approximately 50% among traditional cigarette and heated tobacco consumers [2] - Hilo's sales are expected to increase significantly due to BAT's extensive sales network and marketing resources, contributing to Smoore's core profit growth [2] Group 3 - The core vaping business is recovering and is expected to benefit from the expansion of the compliant market in Europe and the US, with the FDA cautiously supporting the expansion of flavored tobacco products [3] - BAT anticipates that the US market will not hinder the overall growth of new tobacco business revenue, with a projected market share increase of 0.7 percentage points in the US by the end of 2024 [3] Group 4 - The company is projected to have earnings per share (EPS) of 0.22, 0.37, and 0.59 yuan for the years 2025 to 2027, with corresponding price-to-earnings (PE) ratios of 53, 31, and 20 times [4]

Investment Rating - The report maintains a "Buy" rating for the company, expecting a price increase of over 15% in the next 6-12 months [5]. Core Views - The company demonstrates confidence in its future development by repurchasing 8.14 million shares at an average price of 12.26 HKD, totaling 99.77 million HKD [2]. - The Hilo product line is gaining traction, with strong promotional efforts from British American Tobacco (BAT) leading to a 50% retention rate among traditional and heated tobacco consumers, which supports future sales growth [3]. - The core vaping business is recovering, benefiting from regulatory crackdowns on illegal e-cigarettes in the U.S. and a shift in European markets towards compliant products. BAT expects revenue recovery in the U.S. market by the second half of 2025, with a projected market share increase [4]. - The company is well-positioned to capitalize on the expanding compliant vaping market in Europe and the U.S., with a focus on accelerating the global promotion of Hilo products by 2026 [4]. Financial Summary - The company’s projected earnings per share (EPS) for 2025-2027 are 0.22, 0.37, and 0.59 CNY, respectively, with corresponding price-to-earnings (P/E) ratios of 53, 31, and 20 [5]. - Revenue is expected to grow from 11,168 million CNY in 2023 to 20,462 million CNY by 2027, reflecting a compound annual growth rate (CAGR) of approximately 20.48% [10]. - The net profit is projected to recover from 1,303 million CNY in 2024 to 3,656 million CNY by 2027, indicating a significant growth trajectory [10].

Investment Rating - Industry rating is maintained as "Outperform the Market" [7] Core Insights - PMI reported a strong performance in the third quarter of 2025, with revenue reaching $30.3 billion, a year-on-year increase of 7.5%, and gross profit of $20.5 billion, up 12.1% [1] - Smoore achieved record quarterly revenue of $4.197 billion in Q3 2025, marking a 27.2% year-on-year growth [3] - The strong growth in PMI's reduced-risk products, particularly Nicotine Pouches, is a key driver of performance, with shipments increasing by 25.8% year-on-year [2] - Smoore's HNB (Heated Not Burned) business has seen significant growth, supported by successful product launches in international markets [4] Summary by Sections PMI Financial Performance - For the first three quarters of 2025, PMI's revenue was $30.3 billion, with a gross profit of $20.5 billion, and an adjusted diluted EPS of $2.24, reflecting a 17.3% increase [1] - In Q3 alone, revenue was $10.8 billion, with an operating profit of $4.3 billion, showing a 16.7% increase [1] PMI Product Performance - PMI shipped 940 million cans of oral tobacco products in the first three quarters, a 25.8% increase, with Q3 shipments at 313 million cans, up 20.2% [2] - Nicotine Pouches shipments reached 663 million cans in the first three quarters, a 44.0% increase [2] Smoore Financial Performance - Smoore's revenue for the first three quarters was $10.21 billion, a 21.8% increase, with adjusted profit at $1.182 billion, a slight increase of 0.1% [3] - The third quarter revenue of Smoore was a record $4.197 billion, with adjusted profit of $444 million, reflecting a 4.0% year-on-year growth [3] Smoore Product Performance - Smoore's HNB and e-cigarette businesses showed healthy growth, with strategic support for clients leading to increased product launches and compliance with regulations [4] - The introduction of new products and localized marketing efforts have contributed to the growth of Smoore's proprietary brand business [4] Regulatory Environment - Customs authorities in Ningbo and Huangpu seized 265,140 boxes of infringing "ZYN" products, which is expected to strengthen the legitimate supply chain and benefit the compliant oral tobacco industry [5]

Investment Rating - The industry investment rating is "Positive" [2] Core Viewpoints - The report highlights that British American Tobacco's (BAT) new tobacco products are showing signs of profitability recovery, particularly the HNB product Hilo, which is expected to drive future earnings growth [2][3] - For the first half of 2025, BAT reported revenues of £12.069 billion, a year-on-year decrease of 2.2%, but a 1.8% increase when adjusted for fixed exchange rates. New tobacco product revenues remained stable at £1.651 billion, accounting for 13.7% of total revenue [2][3] - The adjusted gross margin for new tobacco products increased by 2.5 percentage points to 59.6%, which is 10 percentage points higher than traditional cigarettes, indicating a potential for continued profitability improvement [2][3] Summary by Sections Revenue Performance - In H1 2025, BAT's revenue from new tobacco products was £1.651 billion, with a stable year-on-year performance and a 2.4% increase when adjusted for fixed exchange rates. This segment accounted for 13.7% of total revenue, up 0.3 percentage points year-on-year [2] - The overall tobacco market is expected to see a 2% decline in sales volume globally in 2025, while BAT anticipates its own growth to be between 1% and 2%, with new tobacco products expected to achieve mid-single-digit growth [2] Product Performance - The vaping segment saw revenues of £740 million in H1 2025, down 15.3% year-on-year, with a volume of 250 million units sold, a decrease of 12.9%. The decline in the US was attributed to illegal disposable products and inventory disruptions, while the European market is recovering due to improved regulatory conditions [2][3] - The HNB segment generated £440 million in revenue, with a slight year-on-year increase of 0.8%. Sales volume was 10.1 billion units, up 1.6%. The APMEA region showed an 8.7% increase in HNB sales, driven by significant contributions from Japan and Kazakhstan [3] - The oral tobacco segment experienced a revenue increase of 38.1% year-on-year, reaching £470 million, with a global market share increase of 4.4 percentage points. The US market saw a remarkable revenue growth of 372% year-on-year, driven by the successful nationwide launch of Velo Plus [4] Market Outlook - The report emphasizes the potential for HNB products to continue driving growth, with a focus on product iteration and market expansion. Key companies to watch include Smoore International, China National Tobacco Corporation, and core suppliers like Xianhe Co. and Yingqu Technology [4]